Equasens: annual sales growth of almost 3%
In the fourth quarter of last year alone, the healthcare software solutions group saw its sales fall to 57 million euros (-5.5% versus the last quarter of 2022, but +0.4% on a like-for-like basis).
"The macro-economic environment looks more favorable in 2024, with a decline in inflation, lower financing rates and an expected upturn in pharmacy activity in the first half of the year", it stresses, however.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction